Surgical Conflicts of Interest: Are They a Problem? Authors: Anthony Vo, Henry Woo, Guy J. Maddern Published: 2026 ABSTRACT ABSTRACTBackgroundSurgeons undertake diverse roles in clinical practice, administration, education, research and innovation. These responsibilities can give rise to conflicts of interest when personal, financial, or professional interests intersect with the fundamental obligations to patient care, research integrity, and ethical conduct. While conflicts of interest are inherent in modern surgical practice, inadequate recognition and management risk undermining ethical decision‐making and public confidence in the profession.MethodsA structured literature search was conducted using the Ovid MEDLINE database to identify relevant publications addressing conflicts of interest in surgical practice. Conflict of interest policies from surgical specialty colleges in Australia, Canada, Ireland, the United Kingdom, and the United States of America were also reviewed. Findings were synthesised narratively.Summary of PoliciesExisting policies demonstrate broad consistency in defining conflicts of interest and emphasising disclosure. However, substantial variability exists in the depth of guidance for identifying, evaluating and managing conflicts. Empirical evidence highlights underreporting of conflicts of interest and associations between industry relationships and favourable research outcomes. Practical, context‐specific strategies for managing complex or evolving conflicts remain limited.ConclusionsConflicts of interest are an inherent aspect of modern surgical practice. However, existing policies often lack practical, context‐specific guidance to address these conflicts. A structured process incorporating identification, disclosure, risk assessment, management, monitoring, and ongoing transparency and accountability should be adopted to uphold professional integrity, support ethical decision‐making, and maintain public trust within surgical practice. Introduction Surgeons undertake diverse responsibilities across clinical practice, administration, education, research and innovation [1] These overlapping roles can give rise to conflicts of interest (COI) when personal, financial or professional interests influence objective clinical judgement and ethical conduct. While COIs are inevitable in modern surgical practice, failure to recognise and appropriately manage these conflicts risks compromising the integrity of clinical decision‐making, quality of patient care and public confidence in healthcare systems [2] Current guidance provides broad principles for identifying and managing COIs. However, there remains a lack of comprehensive, standardised surgery‐specific guidelines that support surgeons in navigating COIs to preserve ethical patient care and clinical integrity. Methods A structured literature search was conducted using the Ovid MEDLINE database to identify publications addressing COIs in surgical practice across clinical care, administration, research, innovation, industry collaboration and academic activities. The full search strategy is presented in Appendix A. Eligibility criteria included peer‐reviewed articles, reviews, policy documents, and guidelines addressing COI in surgery or broader healthcare governance. Studies were excluded if they were unrelated to surgical practice, or did not address COIs within a healthcare context. In addition, publicly available COI policies from surgical specialty colleges based in Australia, Canada, Ireland, the United Kingdom and the United States of America (Table 1) were reviewed to evaluate existing guidance on the identification, disclosure and management of COIs. Given the heterogeneous nature and normative ethical focus of the topic, findings were synthesised narratively to identify key ethical themes, areas of consensus, and points of divergence across the literature and policy documents. This narrative synthesis formed the basis for the analysis and development of the proposed framework. TABLE 1Surgical colleges for which conflict of interest policies were searched.Surgical collegesRoyal Australasian College of Surgeons (RACS)Royal College of Surgeons of England (RCS England)Royal College of Surgeons in Ireland (RCSI)American College of Surgeons (ACS)Royal College of Physicians and Surgeons of Canada (RCPSC) Surgical colleges for which conflict of interest policies were searched. Defining COI COIs arise when professional duty involving primary interests is influenced by secondary interests [3]. In medicine, primary interests include patient safety, quality of care and academic and research integrity. Secondary interests encompass financial gain, relationships with industry, academic recognition, career advancement or personal and professional benefits [4, 5]. Discordance between these interests can compromise clinical judgement, research validity, and trust in the healthcare system. Classifying COI COIs are commonly grouped as actual and potential. Actual COIs occur when decision‐making is directly influenced by a conflicting interest. Potential COIs arise when an interest could influence future decisions. COIs may also be perceived or not perceived, based on whether a reasonable observer could believe bias may be present, irrespective of actual influence [6, 7]. COIs can also be categorised as financial or non‐financial (Table 2). Financial conflicts include employment, investments, consultancies, research funding, royalties and indirect payments. Non‐financial conflicts encompass academic ambition, professional recognition, leadership responsibilities and career advancement. Both forms may exist as actual, potential or perceived conflicts and require appropriate disclosure and management [8]. TABLE 2Classifying conflicts of interest.FinancialSponsorshipsResearch funding and grantsStocks, bonds and equity paymentsConsultancy fees, panel memberships, speaking feesRoyaltiesIndirect payments (funding of travel, accommodation, hospitality, professional development, gifts)Non‐financialPersonal relationshipsInvolvement with advisory or committee boardsAcademic incentivesLeadership and administrative responsibilitiesDesire for professional recognition and career advancementPersonal beliefs or moral convictions Classifying conflicts of interest. COI in Surgery Industry Collaboration in Surgical Practice Collaboration between surgeons and industry has played a critical role in advancing surgical techniques, developing novel devices, and improving patient outcomes. Surgeons' practical expertise is imperative to innovation, device design and procedural refinement; however, such collaboration can introduce significant COIs when financial and professional incentives intersect with clinical decision‐making [1]. Surgeons' dual role in diagnosing and performing surgical procedures amplifies their obligation to deliver optimal care and also establishes an ethical duty to refine and innovate surgical techniques. Financial relationships or sponsorships can inadvertently influence professional judgement, bias product selection or research interpretation, and ultimately can undermine public confidence [9]. Surgical Innovation The deployment of the articular surface replacement (ASR) hip prosthesis serves as a stark example of how surgical innovation can significantly compromise patient safety and ethical standards [10, 11]. Financial incentives for surgeons and institutions, combined with inadequate regulatory oversight, contributed to the widespread adoption of a device later found to be unsafe and ineffective. The surgeons involved in ASR's introduction had financial ties to its manufacturers, raising concerns regarding biased decision‐making despite emerging safety concerns [12]. To mitigate such risks, strategies including mandatory recusal for surgeons with financial interests in a device, independent oversight, and third‐party consent procedures have been suggested [9]. However, implementing these measures does present challenges, including potential delays in innovation and the need for robust institutional support. Financial Investments Financial investments may present potential COIs, particularly where surgeons hold stocks and equity in medical device or pharmaceutical companies, as financial gain may be directly linked to product success. Surgeons with such interests may subconsciously favour newer devices, increase utilisation, or advocate for wider indications, which may not align with the patient's best interest [13]. While a surgeon may genuinely believe a product or device is superior, it remains difficult to fully exclude bias or guarantee the objectivity and integrity of the decision‐making process. Ownership of day surgery centres and other operating facilities presents similar challenges [3]. Surgeons with financial stakes in these centres may face pressures or be incentivised to increase procedural volume and prioritise revenue generation, challenging their fundamental obligations to patient care [14]. Concurrent practice in both public and private healthcare settings represents a structurally embedded COI. Unlike discrete financial relationships, dual practice creates a continuous incentive structure that may influence procedural thresholds, case selection, and utilisation patterns. Management therefore extends beyond disclosure and requires system‐level safeguards, including transparency of dual practice arrangements, audit of procedural indications, and institutional oversight of practice patterns across settings [15]. Involvement With Advisory Boards and Committees Surgeons often serve on governance bodies and advisory committees, where their expertise and practical insights are invaluable in shaping policies grounded in the realities of surgical practice [16]. However, these influential positions can give rise to COIs, particularly when surgeons hold financial, professional or institutional affiliations, which may compromise objectivity and undermine the integrity of governance processes if not transparently managed [17]. Surgical Research COIs are prevalent in surgical research and may influence study design, outcomes and interpretation of results. Systematic reviews demonstrate underreporting and insufficient details of COI disclosures, limiting the assessment of research validity [9, 18]. Discrepancies between self‐reported financial COIs and actual industry payments have been identified across multiple surgical specialties, including in robotic cardiothoracic surgery and vascular surgery studies, where 68% and 63% of authors received undisclosed industry payments, respectively [19, 20]. Industry‐sponsored studies have also been demonstrated to report more favourable outcomes, reflecting industry bias arising from systematic biases in study design, choice of comparators and outcomes, selective analysis, selective reporting and publication bias [21, 22]. Summary of Policies Most surgical specialty colleges have established COI policies. However, the scope, specificity, and practical guidance vary across these policies. Many focus on disclosure but offer limited guidance for managing complex or evolving conflicts. Surgical Specialty Colleges: COIs Policies The Royal Australasian College of Surgeons (RACS) defines COIs broadly and emphasises disclosure and avoidance where possible [23]. The RACS policy also incorporates the impartial observer test, adapted from legal standards, to determine whether a COI exists [24]. Applying the impartial observer test, if a hypothetical, well‐informed, reasonable person would think a member's personal interests could influence their decisions, a COI likely exists and should be disclosed [25]. The Council or committee is then responsible for deciding how best to address the conflict. Once consensus has been achieved, the conflicted member may either: vote on the matter; have access to the related documentation; participate in the debate; be present in the room during the debate and voting; or, in exceptional circumstances, resign from the relevant committee [23]. The American College of Surgeons (ACS) emphasises that patient interests must supersede all other personal, financial and corporate interests [26]. The ACS also maintains a COI policy applicable primarily to the ACS leadership and its affiliated organisations. This policy outlines examples of financial and non‐financial COIs, disclosures required, and the administrative action in response to the identified COIs [27]. The Royal College of Surgeons of England (RCS England) COI policy includes guidance notes and outlines broad examples of conflicts that should be declared. Members are encouraged to ask themselves whether any circumstances related to the interest could potentially compromise the reputation of the College. Should the member respond affirmatively, the matter should be formally declared. The disclosure will then be reviewed by non‐conflicted members to determine appropriate management or mitigation measures to address the conflict [28]. The Royal College of Physicians and Surgeons of Canada (RCPSC) describes COIs and provides a structured procedure for disclosure, requiring members to declare any competing interests that could influence their judgement or actions to the committee, which then determines an appropriate course of action [29]. The Royal College of Surgeons in Ireland (RCSI) COI policy acknowledges the difficulty in recognising and anticipating COIs. The policy also provides explicatory examples of potential conflicts and includes a non‐exhaustive list of mitigation strategies to guide and support members in identifying situations that may compromise professional objectivity [30]. Views From Existing Literature In Australia, the National Health and Medical Research Council (NHMRC) provides a comprehensive framework for identifying and managing COIs in guideline development [8]. While not specific to surgery, this guideline offers a structured framework that can be readily applied to surgical practice. Key considerations when identifying COIs include whether the interest can be eliminated, consistently produce bias, or influence group decision‐making. Where disagreement exists and ethical integrity is at risk, the public scrutiny test can be applied to evaluate whether a decision or relationship would be acceptable if openly disclosed to the public or professional examination [31]. The NHMRC also advocates using structured checklists that detail financial ties and other affiliations, and regularly updating disclosures as circumstances change. Management strategies may include: having conflicted members abstain from relevant discussions or decisions; recusal from meetings; elimination of the conflicting interest; or disallowing input from sponsoring organisations. Such decisions should be made collaboratively and documented to ensure accountability [8]. Discussion COI in Surgical Practice A surgeon's dual responsibility in diagnosing and performing interventions gives rise to COIs that pose significant ethical and professional challenges. While industry collaboration is essential to drive innovation, such sponsorships and equity holdings may bias clinical decision‐making, device selection, and research outcomes. Historical examples, such as the ASR hip prosthesis, demonstrate how financial incentives and inadequate oversight can compromise patient safety and informed consent. Underreporting of COIs and favourable reporting in industry‐sponsored research further highlight the need for standardised disclosure practices and independent oversight to ensure clinical integrity remains paramount in all industry involvement with surgical research. The International Committee of Medical Journal Editors (ICMJE) Form for Disclosure of Potential Conflicts of Interest offers a standardised approach for authors to disclose relationships and activities that could influence their published work [32]. Submission of this form is a requirement for publication by many leading medical journals [33, 34, 35, 36]. Notably, this requirement is not uniformly adopted, with many surgical journals not requiring submission of the disclosure form. Mandating the declaration of COIs through a standardised form would enhance transparency and facilitate the identification of potential conflicts that could impact the validity and interpretation of research findings. However, it does not guarantee complete accuracy, and discrepancies may still arise in how conflicts are reported [37]. COI Policies Across surgical specialty colleges, definitions of COIs are broadly consistent, recognising that actual, potential and perceived conflicts may compromise objectivity and ethical patient care. All colleges emphasise the importance of identifying, disclosing and managing COIs to uphold integrity and public trust. However, the scope and degree of practical guidance provided varies across the policies. The ACS addresses COIs within its broader policy, which primarily reinforces core ethical values for surgeons. While a specific conflict of interest policy exists for ACS leadership, this policy does not appear to extend to the broader membership or practising surgeons outside leadership roles. Without a dedicated policy, surgeons are left with limited practical guidance. The RCPSC policy similarly emphasises the importance of disclosure and provides a structured declaration process, but offers limited guidance on recognising and managing potential COIs. While the RCS England framework outlines clear disclosure procedures and broad examples of conflicts, it provides minimal guidance to mitigate complex or unprecedented scenarios. The RACS policy is notable for incorporating the impartial observer test, an evidence‐based tool, to assess whether bias could reasonably be perceived. This approach encourages reflection on how interests may appear to an informed observer and reinforces transparency and accountability in decision‐making. Similarly, the NHMRC recommends the public scrutiny test as a tool to identify potential COIs. While the impartial observer test focusses on the likelihood of influence on judgement, the public scrutiny test assesses whether the interest or action would withstand public exposure without undermining trust. When applied in conjunction, these tools strengthen the identification of COIs by assessing both objective influence and reputational impact. However, the RACS policy provides limited guidance on managing identified conflicts, leaving considerable discretion to committees and risking inconsistent application, particularly in complex clinical, research and innovation contexts. In contrast, the RCSI policy offers greater clarity by providing explicatory examples of financial, research and academic conflicts, alongside procedural steps for disclosure and a list of mitigation strategies. These strategies could be further strengthened by offering more specific, context‐driven guidance to ensure consistent and effective implementation. The NHMRC guideline also offers a comprehensive framework that could be integrated into surgical policy development. Ultimately, while surgical specialty colleges establish ethical expectations and disclosure requirements, consistent and practical guidance for identifying, evaluating, and managing COIs remains limited. Integrating structured disclosure processes, explicatory examples, and practical mitigation strategies outlined across these various policies would improve consistency and better support surgeons in identifying, managing, and resolving COIs encountered in practice. Proposed Framework for Managing Surgical COI Trigger and Scope Effective management of COIs requires clear identification of when the structured framework should be applied and who is responsible for initiating the process. This framework applies across clinical practice, research, education, and governance. This framework, outlined in Appendix C, is designed for proactive application in any situation where professional judgement or decision‐making may be influenced by secondary interests. Key trigger points include: Clinical practice ○Treatment selection○Device and prosthesis selection○Informed consent○Adoption of new techniques or technologies○Procedural or referral decisions○Concurrent public and private practice arrangements Research and innovation ○Study design○Funding acquisition○Data interpretation○Authorship and publication Education and training ○Curriculum development○Trainee assessment○Industry‐sponsored educational activities Leadership and governance ○Committee participation○Guideline development○Policy formation Clinical practice ○Treatment selection○Device and prosthesis selection○Informed consent○Adoption of new techniques or technologies○Procedural or referral decisions○Concurrent public and private practice arrangements Clinical practice ○Treatment selection○Device and prosthesis selection○Informed consent○Adoption of new techniques or technologies○Procedural or referral decisions○Concurrent public and private practice arrangements ○Treatment selection Treatment selection ○Device and prosthesis selection Device and prosthesis selection ○Informed consent Informed consent ○Adoption of new techniques or technologies Adoption of new techniques or technologies ○Procedural or referral decisions Procedural or referral decisions ○Concurrent public and private practice arrangements Concurrent public and private practice arrangements Research and innovation ○Study design○Funding acquisition○Data interpretation○Authorship and publication Research and innovation ○Study design○Funding acquisition○Data interpretation○Authorship and publication ○Study design Study design ○Funding acquisition Funding acquisition ○Data interpretation Data interpretation ○Authorship and publication Authorship and publication Education and training ○Curriculum development○Trainee assessment○Industry‐sponsored educational activities Education and training ○Curriculum development○Trainee assessment○Industry‐sponsored educational activities ○Curriculum development Curriculum development ○Trainee assessment Trainee assessment ○Industry‐sponsored educational activities Industry‐sponsored educational activities Leadership and governance ○Committee participation○Guideline development○Policy formation Leadership and governance ○Committee participation○Guideline development○Policy formation ○Committee participation Committee participation ○Guideline development Guideline development ○Policy formation Policy formation Early implementation of the framework ensures that conflicts are identified and managed proactively, rather than retrospectively. Identification The first stage involves actively recognising circumstances where personal, financial, academic or institutional interests may influence, or be perceived to influence, professional judgement. These include financial relationships with industry, paid consultancies, personal relationships, research funding, academic incentives and leadership roles. Explicatory examples of such conflicts can be provided by specialty colleges and institutions to better guide members. Tests can also be applied to support the identification of these actual, potential and perceived COIs. Impartial observer test ○Focusses on objective assessment from the perspective of a neutral third party○To apply this test, individuals should ask: “would a reasonably informed observer consider this interest likely to influence judgement or actions?” Public scrutiny test ○Focusses on perception and reputational impact○To apply this test, individuals should ask: “would this interest or action withstand public or professional scrutiny without damaging trust or credibility?” Impartial observer test ○Focusses on objective assessment from the perspective of a neutral third party○To apply this test, individuals should ask: “would a reasonably informed observer consider this interest likely to influence judgement or actions?” Impartial observer test ○Focusses on objective assessment from the perspective of a neutral third party○To apply this test, individuals should ask: “would a reasonably informed observer consider this interest likely to influence judgement or actions?” ○Focusses on objective assessment from the perspective of a neutral third party Focusses on objective assessment from the perspective of a neutral third party ○To apply this test, individuals should ask: “would a reasonably informed observer consider this interest likely to influence judgement or actions?” To apply this test, individuals should ask: “would a reasonably informed observer consider this interest likely to influence judgement or actions?” Public scrutiny test ○Focusses on perception and reputational impact○To apply this test, individuals should ask: “would this interest or action withstand public or professional scrutiny without damaging trust or credibility?” Public scrutiny test ○Focusses on perception and reputational impact○To apply this test, individuals should ask: “would this interest or action withstand public or professional scrutiny without damaging trust or credibility?” ○Focusses on perception and reputational impact Focusses on perception and reputational impact ○To apply this test, individuals should ask: “would this interest or action withstand public or professional scrutiny without damaging trust or credibility?” To apply this test, individuals should ask: “would this interest or action withstand public or professional scrutiny without damaging trust or credibility?” Disclosure Following identification, COIs should be transparently disclosed to the relevant parties, including patients, clinical directors, hospital networks, specialty colleges, research ethics committees, journal editors, and other professional bodies. Disclosures should detail the nature, extent, and relevance of the interest, formally documented with the respective institution's disclosure form. All academic journals should mandate the submission of a COI disclosure form alongside the manuscript for consideration of publication. Disclosures should be periodically reviewed and updated to ensure they accurately reflect current circumstances. Evaluation and Risk Assessment Once disclosed, COIs should then be evaluated to determine the significance and level of risk posed to patient care, research integrity or professional objectivity. Evaluation should consider whether the conflict is: actual, potential or perceived; direct or indirect; financial or non‐financial; and whether it has the potential to influence decision‐making. Risk stratification (low, moderate, high, severe/unmanageable risk) should also be applied, guided by structured domains, including: proximity of the interest to the decision, magnitude of potential benefits, level of decision‐making authority held by the individual, and potential impact on patient outcomes, research integrity, or public trust. Conflicts involving direct financial benefit, high decision‐making authority, and significant potential impact are more likely to be classified as high or unmanageable risk, whereas indirect or low‐magnitude interests with minimal influence may be considered low risk. A summary of risk stratification criteria and corresponding management strategies is provided in Appendix B. This assessment should be conducted by a designated delegate or committee using structured criteria to ensure impartiality in the evaluation process. The outcome can then guide the scope and nature of implemented management strategies. Management Strategies Management of disclosed COIs should be proportionate and align with the level of risk determined during the evaluation process. These possible strategies include: Transparency ○Transparency may be the primary strategy in situations where disclosure alone sufficiently mitigates concerns in low‐risk COIs○Surgeons may retain decision‐making rights, including the ability to vote on matters, while clearly declaring their interests○In clinical settings, transparency may include disclosure of relevant financial or professional relationships to patients during the informed consent process when these relationships may reasonably influence treatment recommendations○Maintaining transparency ensures all stakeholders are aware of potential influences without unnecessarily restricting participation Modification of roles ○In moderate‐risk cases where full participation may not be appropriate, but the surgeon's expertise is still valuable○Role modifications can include allowing access to relevant documentation or participating in discussions, while limiting influence on final decisions.○When providing information or dealing with questions, experts should vacate the meeting at the time of the general discussion or voting to minimise undue pressure on those participating in the decision.○Multidisciplinary review may also provide an additional safeguard in situations where the treating surgeon has competing interests○This approach balances the benefit of specialist input with the need to minimise impartiality Recusal ○Recusal involves abstaining from specific decisions where conflict is considered high‐risk and has the potential to compromise objectivity.○Examples include abstaining from decision‐making processes (such as multidisciplinary meetings or device selection discussions), guideline development or research oversight where financial or personal interests are directly implicated.○In clinical practice, recusal may involve seeking independent review and shared decision‐making or transferring specific aspects of decision‐making (such as implant selection or eligibility for novel procedures) to a non‐conflicted clinician. Withdrawal from roles ○For high‐risk conflicts that cannot be effectively managed through disclosure, modification or recusal, temporary withdrawal from certain roles or activities may be necessary.○This may include withdrawing from specific leadership positions, conflicting committees, advisory boards, or research projects until the conflict is resolved○This focusses on suspension rather than elimination of the relationship or interest. Termination of relationships ○In situations where conflicts pose severe, unmanageable risks that cannot otherwise be mitigated, complete divestment or cessation of the conflicting interest is warranted.○This may involve terminating collaborative financial relationships, resigning from external appointments or relinquishing intellectual property rights that give rise to a conflict. Transparency ○Transparency may be the primary strategy in situations where disclosure alone sufficiently mitigates concerns in low‐risk COIs○Surgeons may retain decision‐making rights, including the ability to vote on matters, while clearly declaring their interests○In clinical settings, transparency may include disclosure of relevant financial or professional relationships to patients during the informed consent process when these relationships may reasonably influence treatment recommendations○Maintaining transparency ensures all stakeholders are aware of potential influences without unnecessarily restricting participation Transparency ○Transparency may be the primary strategy in situations where disclosure alone sufficiently mitigates concerns in low‐risk COIs○Surgeons may retain decision‐making rights, including the ability to vote on matters, while clearly declaring their interests○In clinical settings, transparency may include disclosure of relevant financial or professional relationships to patients during the informed consent process when these relationships may reasonably influence treatment recommendations○Maintaining transparency ensures all stakeholders are aware of potential influences without unnecessarily restricting participation ○Transparency may be the primary strategy in situations where disclosure alone sufficiently mitigates concerns in low‐risk COIs Transparency may be the primary strategy in situations where disclosure alone sufficiently mitigates concerns in low‐risk COIs ○Surgeons may retain decision‐making rights, including the ability to vote on matters, while clearly declaring their interests Surgeons may retain decision‐making rights, including the ability to vote on matters, while clearly declaring their interests ○In clinical settings, transparency may include disclosure of relevant financial or professional relationships to patients during the informed consent process when these relationships may reasonably influence treatment recommendations In clinical settings, transparency may include disclosure of relevant financial or professional relationships to patients during the informed consent process when these relationships may reasonably influence treatment recommendations ○Maintaining transparency ensures all stakeholders are aware of potential influences without unnecessarily restricting participation Maintaining transparency ensures all stakeholders are aware of potential influences without unnecessarily restricting participation Modification of roles ○In moderate‐risk cases where full participation may not be appropriate, but the surgeon's expertise is still valuable○Role modifications can include allowing access to relevant documentation or participating in discussions, while limiting influence on final decisions.○When providing information or dealing with questions, experts should vacate the meeting at the time of the general discussion or voting to minimise undue pressure on those participating in the decision.○Multidisciplinary review may also provide an additional safeguard in situations where the treating surgeon has competing interests○This approach balances the benefit of specialist input with the need to minimise impartiality Modification of roles ○In moderate‐risk cases where full participation may not be appropriate, but the surgeon's expertise is still valuable○Role modifications can include allowing access to relevant documentation or participating in discussions, while limiting influence on final decisions.○When providing information or dealing with questions, experts should vacate the meeting at the time of the general discussion or voting to minimise undue pressure on those participating in the decision.○Multidisciplinary review may also provide an additional safeguard in situations where the treating surgeon has competing interests○This approach balances the benefit of specialist input with the need to minimise impartiality ○In moderate‐risk cases where full participation may not be appropriate, but the surgeon's expertise is still valuable In moderate‐risk cases where full participation may not be appropriate, but the surgeon's expertise is still valuable ○Role modifications can include allowing access to relevant documentation or participating in discussions, while limiting influence on final decisions. Role modifications can include allowing access to relevant documentation or participating in discussions, while limiting influence on final decisions. ○When providing information or dealing with questions, experts should vacate the meeting at the time of the general discussion or voting to minimise undue pressure on those participating in the decision. When providing information or dealing with questions, experts should vacate the meeting at the time of the general discussion or voting to minimise undue pressure on those participating in the decision. ○Multidisciplinary review may also provide an additional safeguard in situations where the treating surgeon has competing interests Multidisciplinary review may also provide an additional safeguard in situations where the treating surgeon has competing interests ○This approach balances the benefit of specialist input with the need to minimise impartiality This approach balances the benefit of specialist input with the need to minimise impartiality Recusal ○Recusal involves abstaining from specific decisions where conflict is considered high‐risk and has the potential to compromise objectivity.○Examples include abstaining from decision‐making processes (such as multidisciplinary meetings or device selection discussions), guideline development or research oversight where financial or personal interests are directly implicated.○In clinical practice, recusal may involve seeking independent review and shared decision‐making or transferring specific aspects of decision‐making (such as implant selection or eligibility for novel procedures) to a non‐conflicted clinician. Recusal ○Recusal involves abstaining from specific decisions where conflict is considered high‐risk and has the potential to compromise objectivity.○Examples include abstaining from decision‐making processes (such as multidisciplinary meetings or device selection discussions), guideline development or research oversight where financial or personal interests are directly implicated.○In clinical practice, recusal may involve seeking independent review and shared decision‐making or transferring specific aspects of decision‐making (such as implant selection or eligibility for novel procedures) to a non‐conflicted clinician. ○Recusal involves abstaining from specific decisions where conflict is considered high‐risk and has the potential to compromise objectivity. Recusal involves abstaining from specific decisions where conflict is considered high‐risk and has the potential to compromise objectivity. ○Examples include abstaining from decision‐making processes (such as multidisciplinary meetings or device selection discussions), guideline development or research oversight where financial or personal interests are directly implicated. Examples include abstaining from decision‐making processes (such as multidisciplinary meetings or device selection discussions), guideline development or research oversight where financial or personal interests are directly implicated. ○In clinical practice, recusal may involve seeking independent review and shared decision‐making or transferring specific aspects of decision‐making (such as implant selection or eligibility for novel procedures) to a non‐conflicted clinician. In clinical practice, recusal may involve seeking independent review and shared decision‐making or transferring specific aspects of decision‐making (such as implant selection or eligibility for novel procedures) to a non‐conflicted clinician. Withdrawal from roles ○For high‐risk conflicts that cannot be effectively managed through disclosure, modification or recusal, temporary withdrawal from certain roles or activities may be necessary.○This may include withdrawing from specific leadership positions, conflicting committees, advisory boards, or research projects until the conflict is resolved○This focusses on suspension rather than elimination of the relationship or interest. Withdrawal from roles ○For high‐risk conflicts that cannot be effectively managed through disclosure, modification or recusal, temporary withdrawal from certain roles or activities may be necessary.○This may include withdrawing from specific leadership positions, conflicting committees, advisory boards, or research projects until the conflict is resolved○This focusses on suspension rather than elimination of the relationship or interest. ○For high‐risk conflicts that cannot be effectively managed through disclosure, modification or recusal, temporary withdrawal from certain roles or activities may be necessary. For high‐risk conflicts that cannot be effectively managed through disclosure, modification or recusal, temporary withdrawal from certain roles or activities may be necessary. ○This may include withdrawing from specific leadership positions, conflicting committees, advisory boards, or research projects until the conflict is resolved This may include withdrawing from specific leadership positions, conflicting committees, advisory boards, or research projects until the conflict is resolved ○This focusses on suspension rather than elimination of the relationship or interest. This focusses on suspension rather than elimination of the relationship or interest. Termination of relationships ○In situations where conflicts pose severe, unmanageable risks that cannot otherwise be mitigated, complete divestment or cessation of the conflicting interest is warranted.○This may involve terminating collaborative financial relationships, resigning from external appointments or relinquishing intellectual property rights that give rise to a conflict. Termination of relationships ○In situations where conflicts pose severe, unmanageable risks that cannot otherwise be mitigated, complete divestment or cessation of the conflicting interest is warranted.○This may involve terminating collaborative financial relationships, resigning from external appointments or relinquishing intellectual property rights that give rise to a conflict. ○In situations where conflicts pose severe, unmanageable risks that cannot otherwise be mitigated, complete divestment or cessation of the conflicting interest is warranted. In situations where conflicts pose severe, unmanageable risks that cannot otherwise be mitigated, complete divestment or cessation of the conflicting interest is warranted. ○This may involve terminating collaborative financial relationships, resigning from external appointments or relinquishing intellectual property rights that give rise to a conflict. This may involve terminating collaborative financial relationships, resigning from external appointments or relinquishing intellectual property rights that give rise to a conflict. Monitoring Disclosed COIs and the respective management plans should be subject to ongoing monitoring to ensure compliance and continued relevance. This includes periodic review of disclosures, monitoring the effectiveness of mitigation strategies, and documenting unresolved conflicts or breaches. The monitoring process may be performed by institutional committees or designated members with the authority to revise management plans as circumstances evolve. Transparency and Accountability Transparency is fundamental to the effective management of COIs. Where appropriate, COI declarations and management plans should be made accessible to the relevant internal and external stakeholders. This may include committee members, journal publishers, peer reviewers, regulatory bodies, and the public. Clear documentation of decisions, underlying rationales, and outcomes should ensue to demonstrate proactive COI management and thereby maintain public trust and reinforce professional integrity. Conclusion COI are an inevitable and multifaceted aspect of modern surgical practice, arising across clinical care, research, innovation and industry collaboration. While existing policies from surgical specialty colleges recognise the impact of COIs and provide a foundation of ethical principles and disclosure requirements, practical guidance on the identification, evaluation and management of conflicts remains variable and often lacks specificity. Implementing evidence‐informed approaches such as the impartial observer test and public scrutiny test can assist in recognising actual, potential and perceived conflicts and further reinforce accountability and integrity. The integration of structured disclosure processes, context‐specific examples and clear management strategies into a surgery‐specific framework can enhance consistency, support ethical decision‐making and ensure patient care remains central. Ultimately, surgeons hold ethical and professional duties to place patient care above all personal and external interests. Accordingly, a comprehensive and practical approach to the management of COI is essential to uphold professional integrity, maintain public trust, and support ethical decision‐making and accountability within surgical practice. Disclosure Professor Guy Maddern is an Editorial board member of ANZ Journal of Surgery and a coauthor of this article. To minimise bias, Professor Guy Maddern was excluded from all the editorial decision‐making related to the acceptance of this article for publication. Conflicts of Interest The authors declare no conflicts of interest.